Carmen Say

3.1k total citations · 1 hit paper
9 papers, 1.0k citations indexed

About

Carmen Say is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carmen Say has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Carmen Say's work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Carmen Say is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Carmen Say collaborates with scholars based in United States and Canada. Carmen Say's co-authors include Maximilian Diehn, Aaron M. Newman, Li Zhou, Robert B. West, Ash A. Alizadeh, Henning Stehr, Justin N. Carter, Billy W. Loo, Alexander F. Lovejoy and Scott V. Bratman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature Biotechnology.

In The Last Decade

Carmen Say

7 papers receiving 1.0k citations

Hit Papers

Integrated digital error suppression for improved detecti... 2016 2026 2019 2022 2016 200 400 600

Peers

Carmen Say
Justin N. Carter United States
Alexander F. Lovejoy United States
Hyunjae R. Kim United States
Jerry Haney United States
Justin N. Carter United States
Carmen Say
Citations per year, relative to Carmen Say Carmen Say (= 1×) peers Justin N. Carter

Countries citing papers authored by Carmen Say

Since Specialization
Citations

This map shows the geographic impact of Carmen Say's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Say with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Say more than expected).

Fields of papers citing papers by Carmen Say

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Say. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Say. The network helps show where Carmen Say may publish in the future.

Co-authorship network of co-authors of Carmen Say

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Say. A scholar is included among the top collaborators of Carmen Say based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Say. Carmen Say is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Merriott, David J., Carmen Say, Christopher H. Yoo, et al.. (2022). Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer. Practical Radiation Oncology. 13(1). e35–e44.
2.
Nishimura, Yoshito, et al.. (2022). Ciprofloxacin-Induced Crystal Nephropathy and Allergic Interstitial Nephritis: Case Report and Review of Literature. SHILAP Revista de lepidopterología. 1(5). 3 indexed citations
3.
Chaudhuri, Aadel A., Alexander F. Lovejoy, Jacob J. Chabon, et al.. (2017). MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer. Journal of Thoracic Oncology. 12(1). S445–S445.
4.
Merriott, David J., Aadel A. Chaudhuri, Jacob J. Chabon, et al.. (2017). Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S20–S21. 1 indexed citations
5.
Jeong, Youngtae, Ngoc T. Hoang, Alexander F. Lovejoy, et al.. (2016). Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. 7(1). 86–101. 243 indexed citations
6.
Chaudhuri, Aadel A., Alex Lovejoy, Jacob J. Chabon, et al.. (2016). CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S41–S42. 3 indexed citations
7.
Newman, Aaron M., Alexander F. Lovejoy, Daniel M. Klass, et al.. (2016). Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. 34(5). 547–555. 716 indexed citations breakdown →
8.
Newman, Aaron M., Alexander F. Lovejoy, Daniel M. Klass, et al.. (2016). Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC.. Journal of Clinical Oncology. 34(15_suppl). e20500–e20500. 1 indexed citations
9.
Kuo, Peiwen, Scott V. Bratman, David Shultz, et al.. (2014). Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. Clinical Cancer Research. 20(21). 5558–5569. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026